The distributor agreement for Egypt and Iraq with Enox Pharma is not extended
Calmark Sweden AB (publ) announced today that the exclusive distributor agreement for the Egyptian and Iraqi markets with the company Enox Pharma AB will not be extended to 2023.The search for a new distributor for these countries is ongoing. The exclusive agreement with Enox Pharma AB regarding marketing and sales of Calmark's products in Bahrain and the United Arab Emirates remains and will be extended. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.